Interkeratin peptide-protein interactions that promote HPV16 E7 gene expression

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 3, 2010, Pages 857-864

  Lucchese, A ^a   Serpico, R ^a   Guida, A ^a   Crincoli, V ^b   Scully, C ^c   Kanduc, D ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CK19; HPV16 E7 translational regulation; Peptide therapy; Peptide protein interactions

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 7; MESSENGER RNA; POLYPEPTIDE; PROTEIN E7;

ARTICLE; CARCINOGENESIS; CELL LYSATE; GENE EXPRESSION; GENE SILENCING; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION; UTERINE CERVIX CANCER;

EID: 78149261662     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300321     Document Type: Article

References (30)

1. Desaintes C, Demeret C. Control of papillomavirus DNA replication and transcription. Semin Cancer Biol 1996; 7:339-7.
2. Mullink H, Jiwa NM, Walboomers JM, Horstman A, Vos W, Meijer CJ. Demonstration of changes in cytokeratin expression in condylomata accuminata in relation to the presence of human papilloma virus as shown by a combination of immunohistochemistry and in situ hybridization. Am J Dermatopathol 1991; 13:530-7.
3. Sun Q, Tsutsumi K, Yokoyama M, Pater MM, Pater A. In vivo cytokeratin-expression pattern of stratified squamous epithelium from human papillomavirus-type-16-immortalized ectocervical and foreskin keratinocytes. Int J Cancer 1993; 54:656-62.
4. Molés J-P, Schiller JT, Tesniere A, Leigh IM, Guilhou J-J, Basset-Séguin N. Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J Cell Sci 1994; 107:435-41.
5. Yuan CC, Huang TS, Ng HT, Liu RS, Hung MW, Tsai LC. Elevated cytokeratin-19 expression associated with apoptotic resistance and malignant progression of human cervical cancer. Apoptosis 1998; 3:161-9.
6. Kanduc D. Translational regulation of human papillomavirus type 16 E7 mRNA by the peptide SEQIKA, shared by rabbit alpha(1)-globin and human cytokeratin 7. J Virol 2002; 76:7040-8.
7. Favia G, Kanduc D, Lo Muzio L, Lucchese A, Serpico R. Possible association between HPV16 E7 protein level and cytokeratin 19. Int J Cancer 2004; 111:795-7.
8. De Pasquale C, Kanduc D. Modulation of HPV16 E7 translation by tRNAs in eukaryotic cell-free translation systems. Biochem Mol Biol Int 1998; 45:1005-9.
9. Stacey SN, Jordan D, Snijders PFJ, Mackett M, Walboomers JMM, Arrand JR. Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame. J Virol 1995; 69:7023-31.
10. Reinstein E, Scheffner M, Oren M, Ciechanover A, Schwartz A. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene 2000; 19:5944-50.
11. Oh KJ, Kalinina A, Park NH, Bagchi S. Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein. J Virol 2006; 80:7079-88.
12. Bruno T, Corbi N, Di Padova M, De Angelis R, Floridi A, Passananti C, Fanciulli M. The RNA polymerase II core subunit 11 interacts with keratin 19, a component of the intermediate filament proteins. FEBS Lett 1999; 453:273-7.
13. Ramaekers F, van Niekerk C, Poels L, Schaafsma E, Huijsmans A, Robben H, Schaart G, Vooijs P. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990; 136:641-55.
14. Johnson LD, Easterday CL, Gore H, Hertig AT. The histogenesis of carcinoma in situ of the uterine cervix. Cancer 1964; 17:213-29.
15. Singer A, Jordan JA. The anatomy of the cervix. In: The cervix, Jordan JA, Singer A, (eds) 1976; pp 132-43. W.B. Saunders & Co, London.
16. Schon M, Benwood J, O'Connell-Willstaedt T, Rheinwald JG. Human sweat gland myoepithelial cells express a unique set of cytokeratins and reveal the potential for alternative epithelial and mesenchymal differentiation states in culture. J Cell Sci 1999; 112:1925-36.
17. Fradette J, Germain L, Seshaiah P, Coulombe PA. The type I keratin 19 possesses distinct and context-dependent assembly properties. J Biol Chem 1998; 273:35176-84.
18. Kanaji N, Bandoh S, Fujita J, Ishii T, Ishida T, Kubo A. Compensation of type I and type II cytokeratin pools in lung cancer. Lung Cancer 2007; 55:295-302.
19. Brembeck FH, Rustgi AK. The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1. J Biol Chem 2000; 275:28230-9.
20. Zheng ZM, Baker CC. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 2006; 11:2286-302.
21. Zhou J, Liu WJ, Peng SW, Sun XY, Frazer IH. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J Virol 1999; 73:4972-82.
22. Mossadegh N, Gissmann L, Müller M, Zentgraf H, Alonso A, Tomakidi P. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology 2004; 326:57-66.
23. Cid-Arregui A, Juárez V, zur Hausen H. A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J Virol 2003; 77:4928-37.
24. Steinberg T, Ohlschläger P, Sehr P, Osen W, Gissmann L. Modification of HPV16 E7 genes: correlation between the level of protein expression and CTL response immunization of C57BL/6 mice. Vaccine 2005; 23:1149-57.
25. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002; 40:403-39.
26. Tomakidi P, Stark HJ, Herold-Mende C, Bosch FX, Steinbauer H, Fusenig NE, Breitkreutz D. Discriminating expression of differentiation markers evolves in transplants of benign and malignant human skin keratinocytes through stromal interactions. J Pathol 2003; 200:298-307.
27. zur Hausen H. Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol 1999; 9:405-11.
28. Liu Z, Ghai J, Ostrow RS, Faras AJ. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential. Virology 1995; 207:260-70.
29. Psyrri A, DeFilippis RA, Edwards AP, Yates KE, Manuelidis L, DiMaio D. Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells. Cancer Res 2004; 64:3079-86.
30. Slade BA, Leidel L, Vellozzi C, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009; 302:750-7.